Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

157.50
Delayed Data
As of May 25
 +0.53 / +0.34%
Today’s Change
117.38
Today|||52-Week Range
178.25
+5.10%
Year-to-Date

Today’s Trading

Previous close156.97
Today’s open157.00
Day’s range156.22 - 157.90
Volume653,584
Average volume (3 months)1,664,700
Market cap$40.1B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+65.41%
Earnings growth (next 5 years)+46.50%
Revenue growth (last year)+46.20%
P/E ratio183.1
Price/Sales15.25
Price/Book19.66

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.12+0.17%
SHPGShire+0.73+0.44%
ALXNAlexion Pharmaceutic...+0.60+0.51%
ZTSZoetis Inc-1.08-1.27%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateJuly 31, 2018
EPS forecast (this quarter)$0.74
Annual revenue (last year)$2.5B
Annual profit (last year)$263.2M
Net profit margin10.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
Chief Operating Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Boston, Massachusetts

Forecasts